Opus Genetics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Opus Genetics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Opus Genetics, Inc. Return On Equity for the quarter ending September 30, 2024 was -63.6 %, a 197% decline year-over-year.
  • Opus Genetics, Inc. annual Return On Equity for 2023 was -22.3 %, a 128% decline from 2022.
  • Opus Genetics, Inc. annual Return On Equity for 2022 was 79.5 %.
  • Opus Genetics, Inc. annual Return On Equity for 2021 was -302 %, a 223% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -22.3 -102 -128% Jan 1, 2023 Dec 31, 2023
2022 79.5 +381 Jan 1, 2022 Dec 31, 2022
2021 -302 -547 -223% Jan 1, 2021 Dec 31, 2021
2020 245 +319 Jan 1, 2020 Dec 31, 2020
2019 -73.1 +112 +60.4% Jan 1, 2019 Dec 31, 2019
2018 -185 +22.1 +10.7% Jan 1, 2018 Dec 31, 2018
2017 -207 -152 -274% Jan 1, 2017 Dec 31, 2017
2016 -55.3 +15.5 +21.9% Jan 1, 2016 Dec 31, 2016
2015 -70.8 -5.52 -8.46% Jan 1, 2015 Dec 31, 2015
2014 -65.3 +39.3 +37.6% Jan 1, 2014 Dec 31, 2014
2013 -105 -23.1 -28.4% Jan 1, 2013 Dec 31, 2013
2012 -81.4 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.